KoBioLabs Inc
348150StockKQ
3,895.00 ▲ +1.70%
Jun 12, 2026
3
KoBioLabs Inc
3,895.00 ▲ +1.70%
Jun 12, 2026
348150StockKQ

About the company

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.

Arberion
Loading market data